Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Assets Average: 2020-2023

Historic Assets Average for ADC Therapeutics (ADCT) over the last 3 years, with Sep 2023 value amounting to $487.1 million.

  • ADC Therapeutics' Assets Average fell 7.41% to $487.1 million in Q3 2023 from the same period last year, while for Sep 2023 it was $487.1 million, marking a year-over-year decrease of 7.41%. This contributed to the annual value of $245.7 million for FY2022, which is N/A change from last year.
  • Per ADC Therapeutics' latest filing, its Assets Average stood at $487.1 million for Q3 2023, which was down 0.08% from $487.5 million recorded in Q2 2023.
  • Over the past 5 years, ADC Therapeutics' Assets Average peaked at $551.2 million during Q3 2021, and registered a low of $447,684 during Q3 2020.
  • In the last 3 years, ADC Therapeutics' Assets Average had a median value of $487.1 million in 2023 and averaged $445.3 million.
  • Its Assets Average has fluctuated over the past 5 years, first surged by 123,018.65% in 2021, then dropped by 11.55% in 2023.
  • Quarterly analysis of 4 years shows ADC Therapeutics' Assets Average stood at $447,684 in 2020, then skyrocketed by 123,018.65% to $319.3 million in 2021, then skyrocketed by 60.14% to $511.3 million in 2022, then declined by 7.41% to $487.1 million in 2023.
  • Its Assets Average stands at $487.1 million for Q3 2023, versus $487.5 million for Q2 2023 and $479.3 million for Q1 2023.